Severity
Moderate
FDA Devices recall · Reported September 9, 2015
A reduction in the reconstituted stability has been identified. Clinicians may notice a drop in recovery of the control after reconstitution, which could result in an out of spec…
Pointe Scientific, Inc. recalled Pointe Scientific G6PD Controls Kit configuration: 6 x 0.5 ml (2 vials each of Level 1,… - a moderate-severity action.
Pointe Scientific G6PD Controls Kit configuration: 6 x 0.5 ml (2 vials each of Level 1,… was recalled by Pointe Scientific, Inc. in September 9, 2015. Reason: A reduction in the reconstituted stability has been identified. Clinicians may notice a drop in recovery of …. Check the official notice for the remedy. Verify recall #Z-2487-2015 with the FDA Devices before acting.
The recall
Pointe Scientific, Inc. issued this moderate-severity FDA Devices recall-A reduction in the reconstituted stability has been identified. Clinicians may notice a drop in recovery of ….
Sourced from official FDA Devices enforcement records. Verify recall #Z-2487-2015 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Devices action (record #Z-2487-2015) was formally reported on September 9, 2015, with the manufacturer initiating the action on May 19, 2015. It is classified under Moderate severity (Class II), with a current status of Terminated. Pointe Scientific, Inc. is listed as the recalling firm, operating out of Canton, MI. Federal records list the affected scope as 2772 total vials (374 kits of 6 vials, 528 invidually sold vials).
The documented reason for this recall is: A reduction in the reconstituted stability has been identified. Clinicians may notice a drop in recovery of the control after reconstitution, which could result in an out of specification result prior to the current re… Distribution data in the federal record shows the product reached: Worldwide distribution: US (nationwide) including states of: PA, CA, KY, FL, NJ, DE, MI, MN,and IL; and countries of: United Arab Emirates, Austria, Italy, Israel, Greece, and Australia.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 3 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 40,322 medical devices recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
2772 total vials (374 kits of 6 vials, 528 invidually sold vials)
Related Recalls
6
3 from same agency
Pointe Scientific G6PD Controls Kit configuration: 6 x 0.5 ml (2 vials each of Level 1, Level 2 and Level 3). Also sold as individual vials Bottle: Clear glass vials Cap: Rubber seal with colored aluminum seals Glucose-6-phosphate dehydrogenase (G6PD) controls can be used to test for the quantitative and qualitative determination of G6PD in blood.
A reduction in the reconstituted stability has been identified. Clinicians may notice a drop in recovery of the control after reconstitution, which could result in an out of specification result prior to the current reconstitution claim of 7 days. For this reason we suggest discontinuing use of the control set.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | Z-2487-2015 |
| Date reported | September 9, 2015 |
| Date initiated | May 19, 2015 |
| Recalling firm | Pointe Scientific, Inc. |
| Firm location | Canton, MI |
| Affected scope | 2772 total vials (374 kits of 6 vials, 528 invidually sold vials) |
| Distribution | Worldwide distribution: US (nationwide) including states of: PA, CA, KY, FL, NJ, DE, MI, MN,and IL; and countries of: United Arab Emirates, Austria, Italy, Israel, Greece, and Australia. |
Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
· 2026-07-02
· 2026-06-25
· 2026-06-18
GE Medical Systems Information Technologies Inc · 2026-06-03
Medline Industries, LP · 2026-06-03
Compare this recall with Rowenta Recalls Cordless Vacuum Cleaners Due to Risk of Ser… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Devices, reported September 9, 2015. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.